Departamento de Planejamento, Políticas e Administração em Saúde, Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Rev Saude Publica. 2010 Feb;44(1):190-6. doi: 10.1590/s0034-89102010000100021.
The paper deals with the pharmaceutical industry's links to the knowledge industry, through powerful marketing strategies. With the aim of scientifically legitimizing its products, the pharmaceutical industry interferes with the production of medical knowledge. In the form of a mechanism for directing economic interests, it funds drug research, biases its results and stimulates the production and publication of scientific papers. This is a mechanism that threatens important ethical issues: it transforms the process of scientific legitimization into a marketing strategy, compromises the credibility of the process of constructing medical knowledge and encourages distortions of the criteria for evaluating the quality of scientific papers.
本文探讨了制药行业通过强大的营销策略与知识产业的联系。制药行业以科学合理地推广其产品为目标，干扰了医学知识的生产。它以一种引导经济利益的机制为形式，为药物研究提供资金，使研究结果产生偏差，并刺激科学论文的生产和发表。这是一种威胁到重要伦理问题的机制：它将科学合法化的过程转化为营销策略，损害了构建医学知识过程的可信度，并鼓励了评估科学论文质量标准的扭曲。
